Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE recommends Nivolumab for invasive urothelial cancer

July 8, 2022
Medical Communications

NICE has published final draft guidance recommending nivolumab for treating some people with invasive urothelial cancer at a high risk …

News

New funding announced to support future dementia research

July 8, 2022
Medical Communications

The NIHR has introduced £11.8 million in funding for promising early career researchers to pursue dementia research. The institute, working …

News

Scientists discover key to hepatitis A replication

July 8, 2022
Medical Communications

UNC School of Medicine scientists discovered the key to hepatitis A virus (HAV) replication. They also found an oral compound …

News

Destiny Pharma announces positive data from antibacterial treatment study

July 7, 2022
Business Services

Destiny Pharma has announced the publication of new data on XF-73, which is shown to enhance the activity of two …

News

CardiaTec raises £1.4m to combat cardiovascular disease with AI

July 7, 2022
Business Services

CardiaTec Biosciences has secured a £1.4 million pre-seed investment led by Laidlaw Scholars Ventures and APEX Ventures. The company is …

News

Highly contagious COVID-19 subvariants pose threat to immune protection

July 7, 2022
Business Services

The COVID-19 subvariants BA.4 and BA.5 have been found to be the most contagious variants yet, and are better able …

News

CureVac and BioNTech enter legal battle over mRNA vaccine technology

July 7, 2022
Business Services

CureVac has filed a lawsuit against BioNTech, as well as two of its subsidiaries, for allegedly infringing on its intellectual …

News

Sajid Javid resigns as Health Secretary, Steve Barclay appointed

July 6, 2022
Research and Development

Steve Barclay former chief of staff at Number 10 Downing Street, has been appointed new Health Secretary, following the resignation …

News

ADHD treatment may be effective in treating Alzheimer’s disease

July 6, 2022
Research and Development

Clinical trials of noradrenergic drugs, which include antidepressants and medicines to treat high blood pressure and ADHD are now warranted, …

News

Hospitals around UK reintroduce mandatory face masks amid COVID surge

July 5, 2022
Manufacturing and Production

Patients, visitors and staff are once again being told to wear face masks in hospitals across the UK, due to …

News

Mogrify and Astellas collaborate for research on treatments for sensorineural hearing loss

July 5, 2022
Manufacturing and Production

Mogrify and Astellas have announced a collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing …

News

New test aims to tackle prostate cancer rates in Black men

July 5, 2022
Manufacturing and Production

A new genetic blood test is being developed for Black men, using DNA information and AI technology, aiming to combat …

News

COVID-19 hospital cases expected to rise

July 4, 2022
Sales and Marketing

The CEO of UKSHA has said that the number of people being admitted to hospital with COVID-19 is expected to …

News

Liver injuries trigger clinical hold on Sanofi’s BTK drug

July 4, 2022
Sales and Marketing

The FDA has placed a partial clinical hold on Sanofi’s Phase III BTK inhibitor trial, following reports of drug-induced liver …

News

Knee replacement NHS policies on patient’s weight worsened health inequalities

July 4, 2022
Sales and Marketing

New research has found that weight/body mass index (BMI) policies introduced by NHS commissioning groups in England are associated with …

News

Long-Term Impact of Prophylactic Orladeyo on Hereditary Angioedema

July 4, 2022
Sales and Marketing

BioCryst Pharmaceuticals have shared new 96-week data from the open-label global randomised Phase III Apex-2 trial, and an independent six …

News

NHS in “urgent” appeal for more blood donors in Manchester

July 1, 2022

NHS Blood and Transplant is “urgently” appealing for people to make an appointment to donate at one of the two …

News

NHS privatisation linked to rise in avoidable deaths

July 1, 2022
Medical Communications

NHS privatisation was connected to over 500 deaths from treatable diseases in England over five years, a study from Oxford …

News

Sirana Pharma collaborates with Pfizer to investigate rare disease treatment

July 1, 2022
Medical Communications

Sirana Pharma has announced a collaboration with Pfizer to investigate the potential identification and validation of a novel treatment concept …

News

HIV accelerates body’s aging soon after initial infection

July 1, 2022
Medical Communications

Scientists have discovered that accelerated aging with HIV begins at the time of initial HIV infection. Researchers found that HIV …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025